110 related articles for article (PubMed ID: 35594505)
1. Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis.
Strouse CS; Larson MC; Ehlers SL; Yost KJ; Maurer MJ; Ansell SM; Inwards DJ; Johnston PB; Micallef IN; Link BK; Farooq U; Cerhan JR; Thompson CA
JCO Oncol Pract; 2022 Jul; 18(7):e1069-e1080. PubMed ID: 35594505
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience.
Galligan D; Williamson S; Myers J; Chen AI; Hayes-Lattin B; Okada C; Spurgeon S; Maziarz R; Schachter L
Clin Lymphoma Myeloma Leuk; 2023 Dec; 23(12):874-881. PubMed ID: 37741763
[TBL] [Abstract][Full Text] [Related]
3. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):157-161. PubMed ID: 31521818
[TBL] [Abstract][Full Text] [Related]
6. Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Othman T; Quan MA; Zhang S; Gaut D; Young PA; Mahmood O; Abdulhaq H; Shieh K; Reid J; Brem EA; Hariharan N; Heyman B; Tuscano J
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):749-756. PubMed ID: 37336714
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
Smith SM; Burns LJ; van Besien K; Lerademacher J; He W; Fenske TS; Suzuki R; Hsu JW; Schouten HC; Hale GA; Holmberg LA; Sureda A; Freytes CO; Maziarz RT; Inwards DJ; Gale RP; Gross TG; Cairo MS; Costa LJ; Lazarus HM; Wiernik PH; Maharaj D; Laport GG; Montoto S; Hari PN
J Clin Oncol; 2013 Sep; 31(25):3100-9. PubMed ID: 23897963
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic cell transplantation for AML in first remission - An abandoned practice or promising approach?
Yeshurun M; Wolach O
Semin Hematol; 2019 Apr; 56(2):139-146. PubMed ID: 30926090
[TBL] [Abstract][Full Text] [Related]
9. Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.
Nawas MT; Sheng Y; Huang CY; Andreadis C; Martin TG; Wolf JL; Ai WZ; Kaplan LD; Mannis GN; Logan AC; Damon LE; Olin RL
J Geriatr Oncol; 2021 May; 12(4):531-539. PubMed ID: 33059999
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation.
El-Jawahri AR; Traeger LN; Kuzmuk K; Eusebio JR; Vandusen HB; Shin JA; Keenan T; Gallagher ER; Greer JA; Pirl WF; Jackson VA; Ballen KK; Spitzer TR; Graubert TA; McAfee SL; Dey BR; Chen YB; Temel JS
Cancer; 2015 Mar; 121(6):951-9. PubMed ID: 25469752
[TBL] [Abstract][Full Text] [Related]
11. Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
Nawas MT; Andreadis C; Martin TG; Wolf JL; Ai WZ; Kaplan LD; Mannis GN; Logan AC; Damon LE; Huang CY; Olin RL
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1218-1224. PubMed ID: 30708189
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Mathanda RR; Hamilton BK; Rybicki L; Advani AS; Colver A; Dabney J; Ferraro C; Hanna R; Kalaycio M; Lawrence C; McLellan L; Sobecks R; Majhail NS; Rotz SJ
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1505-1510. PubMed ID: 32439476
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study.
Davidov M; Perry C; Herishanu Y; Sarid N; Rom E; Amit O; Eshel R; Naparstek E; Avivi I; Ram R
Ann Hematol; 2018 Mar; 97(3):459-466. PubMed ID: 29177562
[TBL] [Abstract][Full Text] [Related]
14. [Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology].
Janicsák H; Masszi T; Reményi P; Ungvari GS; Gazdag G
Ideggyogy Sz; 2023 Jan; 76(1-2):25-35. PubMed ID: 36892298
[TBL] [Abstract][Full Text] [Related]
15. Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.
Derman BA; Kordas K; Molloy E; Chow S; Dale W; Jakubowiak AJ; Jasielec J; Kline JP; Kosuri S; Lee SM; Liu H; Riedell PA; Smith SM; Bishop MR; Artz AS
J Geriatr Oncol; 2021 May; 12(4):585-591. PubMed ID: 33162369
[TBL] [Abstract][Full Text] [Related]
16. Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma.
Thompson CA; Yost KJ; Maurer MJ; Allmer C; Farooq U; Habermann TM; Inwards DJ; Macon WR; Link BK; Rosenthal AC; Cerhan JR
Hematol Oncol; 2018 Dec; 36(5):749-756. PubMed ID: 29862550
[TBL] [Abstract][Full Text] [Related]
17. Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study.
Devins GM; Mah K; Messner HA; Xenocostas A; Gauvin L; Lipton JH
Support Care Cancer; 2018 Jul; 26(7):2379-2386. PubMed ID: 29423678
[TBL] [Abstract][Full Text] [Related]
18. Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients.
Davis L; Yao Y; Jin Z; Moscoso S; Neunert C; Broglie L; Hall M; Bhatia M; George D; Garvin JH; Satwani P
Transplant Cell Ther; 2021 Jul; 27(7):613.e1-613.e7. PubMed ID: 33831624
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
Adrianzen Herrera D; Kornblum N; Derman O; Bachier-Rodriguez L; Sica RA; Shastri A; Janakiram M; Verma A; Braunschweig I; Mantzaris I
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):516-521. PubMed ID: 31227357
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
